These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23292616)

  • 1. Topical dorzolamide treatment of macular cysts in the enhanced S-cone syndrome patient.
    Kiszkielis M; Lubiński W; Penkala K
    Doc Ophthalmol; 2013 Jun; 126(3):241-6. PubMed ID: 23292616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.
    Bušić M; Bjeloš M; Bosnar D; Ramić S; Bušić I
    Doc Ophthalmol; 2016 Feb; 132(1):67-73. PubMed ID: 26803827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome.
    Genead MA; Fishman GA; McAnany JJ
    Doc Ophthalmol; 2010 Dec; 121(3):231-40. PubMed ID: 20842519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
    Dwivedi R; Tiroumal S
    Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
    Genead MA; Fishman GA
    Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA; Fishman GA; Walia S
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.
    Ikeda Y; Hisatomi T; Yoshida N; Notomi S; Murakami Y; Enaida H; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Fiscella RG; Adelman AE
    Retina; 1997; 17(3):222-31. PubMed ID: 9196934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa.
    Ikeda Y; Yoshida N; Notomi S; Murakami Y; Hisatomi T; Enaida H; Ishibashi T
    Br J Ophthalmol; 2013 Sep; 97(9):1187-91. PubMed ID: 23782868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome.
    Lemos Reis RF; Moreira-Gonçalves N; Estrela Silva SE; Brandão EM; Falcão-Reis FM
    Ophthalmologica; 2015; 233(1):43-50. PubMed ID: 25428176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of bilateral foveal cysts in dome-shaped macula after treatment with topical dorzolamide.
    Vukkadala T; Gowdar Kuberappa R; Azad SV; Kumar V
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33408104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigmented paravenous retinochoroidal atrophy associated with unilateral cystoid macular oedema.
    Figueiredo R; Morais Sarmento T; Garrido J; Ramalho A
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Topical Dorzolamide on Cystoid Macular Edema in Retinitis Pigmentosa.
    Shimokawa S; Fujiwara K; Murakami Y; Funatsu J; Nakatake S; Yoshida N; Sonoda KH; Ikeda Y
    Ophthalmol Retina; 2020 Oct; 4(10):1036-1039. PubMed ID: 32454228
    [No Abstract]   [Full Text] [Related]  

  • 14. TOPICAL DORZOLAMIDE FOR CYSTOID MACULAR EDEMA IN BIETTI CRYSTALLINE RETINAL DYSTROPHY.
    Khojasteh H; Roohipoor R; Riazi-Esfahani H; Ghasempour M
    Retin Cases Brief Rep; 2021 May; 15(3):306-309. PubMed ID: 30028788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fundus Autofluorescence and SD-OCT Document Rapid Progression in Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Associated with a c.256G > A Mutation in BEST1.
    Kellner S; Stöhr H; Fiebig B; Weinitz S; Farmand G; Kellner U; Weber BH
    Ophthalmic Genet; 2016 Jun; 37(2):201-8. PubMed ID: 26771239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.
    Genead MA; McAnany JJ; Fishman GA
    Retina; 2012 Apr; 32(4):826-33. PubMed ID: 21886018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of dorzolamide for patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA
    Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STELLATE NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS: RESPONSE TO TOPICAL DORZOLAMIDE THERAPY.
    Ajlan RS; Hammamji KS
    Retin Cases Brief Rep; 2019; 13(4):364-366. PubMed ID: 28557864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Apushkin MA; Fishman GA
    Am J Ophthalmol; 2006 May; 141(5):850-8. PubMed ID: 16546110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral giant macular schisis in a case of Goldmann-Favre syndrome.
    Chawla R; Banerjee M
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31558488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.